| 9:00 a.m.– 12:10 p.m. |
Welcome Remarks Marc Tessier-Lavigne, Ph.D. President and Carson Family Professor, The Rockefeller University |
| |
What do Chemokines have to do with Fc Receptors? Andrew D. Luster, M.D., Ph.D. Chief, Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital; Persis, Cyrus and Marlow B. Harrison Professor of Medicine, Harvard Medical School |
| |
Antibody responses in humans and mice Michel C. Nussenzweig, M.D., Ph.D.Zanvil A. Cohn and Ralph M. Steinman Professor, Laboratory of Molecular Immunology, The Rockefeller University |
| |
Instructive selection of germinal center B cells into the memory compartment Tomohiro Kurosaki, M.D., Ph.D.Professor, Laboratory of Lymphocyte Differentiation, Immunology Frontier Research Center, Osaka University |
| |
A systems approach to dissecting immunity Alan A. Aderem, Ph.D.Affiliate Professor, Immunology and Medicine, University of Washington; President and Director, Seattle Biomedical Research Institute |
| |
Fc of agonistic antibodies Fubin Li, Ph.D.Principal Investigator, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Immunology |
| |
Beyond anti–TNF therapy for rheumatoid arthritis: can we get closer to a cure? Sir Marc Feldmann, Ph.D., M.B.B.S.Professor and Head, Kennedy Institute of Rheumatology, University of Oxford |
| 12:10 – 1:30 p.m. |
Lunch Break |
| 1:30 – 3:30 p.m. |
Regulatory receptors characterizing peripheral B-lineage cells in SLE Toshiyuki Takai, Ph.D.Professor, Laboratory of Experimental Immunology, Tohoku University School of Medicine |
| |
Reprogramming tumor associated macrophages by antibody targeting Mikael Karlsson, Ph.D.Professor, Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Sweden |
| |
Immune-mediated control of malignant disease Roger M. Perlmutter, M.D., Ph.D. Executive Vice President and President of Merck Research Laboratories, Merck & Co. Inc. |
| |
Glycan regulation of immunoglobulins Robert M. Anthony, Ph.D. Principal Investigator, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School |
| 3:30 – 3:45 p.m. |
Break |
| 3:45 – 5:30 p.m. |
The regulation of immune responses by self-derived molecules Tadatsugu Taniguchi, Ph.D. Professor Emeritus and Project Professor, Department of Molecular Immunology, Institute of Industrial Science of The University of Tokyo |
| |
Novel humanized mouse models to understand and modulate human IgG activity Falk Nimmerjahn, Ph.D. Professor, Department of Biology, University of Erlangen-Nuremberg |
| |
Evolution of adaptive immunity Max D. Cooper, M.D. Professor, Department of Pathology & Laboratory Medicine, Professor, Emory Vaccine Center, and Investigator, Emory Center for AIDS Research, Emory University School of Medicine |
| |
Closing Remarks Jeffrey V. Ravetch, M.D., Ph.D. Theresa and Eugene M. Lang Professor, Leonard Wagner Laboratory of Molecular Genetics and Immunology, The Rockefeller University |